MLANA and neoplasm: In the framework of Ag specific cancer vaccines, we have reported that peptide-vaccination combined with chemotherapy is able to induce a diversification of Melan-A-specific T-cell repertoire in the peripheral blood of long-surviving melanoma patients, with a turn-over of new polyfunctional and tumor-reactive clonotypes [72, 73].